Everyday Health on MSN

What Is the MS Prodrome?

Explore the concept of the MS prodrome, a period with subtle symptoms before multiple sclerosis onset. Learn about early ...

Oculis Reports Q3 2025 Financial Results and Provides Company Update

Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) ...
European Medical Journal

Allergic Rhinitis and Optic Neuritis Link Uncovered

Discover a study linking allergic rhinitis to a higher risk of optic neuritis, revealing shared inflammatory pathways and key clinical insights.

Oculis to Participate in Upcoming November Investor Conferences

Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ...

Oculis Holding AG: Oculis Reports Q3 2025 Financial Results and Provides Company Update

Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic ...
Medscape

Allergic Diseases Tied to Increased Risk for Optic Neuritis

A nationwide cohort study of more than 4 million adults showed that people with allergic diseases were nearly one third more likely to develop optic neuritis than those without such conditions, with ...
WTNH

Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy

ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic ...